Exelixis Inc (EXEL) Dividend History

Exelixis Inc (EXEL) is a biotechnology company focused on developing and commercializing innovative therapies for cancer. Founded in 1994, the company has developed a portfolio of targeted treatments, including cabozantinib, which is used for the treatment of multiple types of cancer such as kidney, liver, and thyroid cancers. Exelixis emphasizes research in oncology and aims to advance therapies that improve patient outcomes.

1851 Harbor Bay Parkway, Alameda, CA, 94502
Phone: (650) 837-7000
Website:

Dividend History

Exelixis Inc currently does not pay dividends

Company News

Dividend data last updated 06/07/2025 15:24:50 UTC